Navigation Links
Bradmer to present at the 10th Annual BIO CEO & Investor Conference
Date:2/8/2008

TSX: BMR

TORONTO, Feb. 8 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, today announced that Dr. Alan M. Ezrin, President and Chief Executive Officer of the Company, will participate as a presenter and panelist at the 10th Annual BIO CEO & Investor Conference. Dr. Ezrin will provide an update on the Company's preparations for the planned Phase III trial for Neuradiab, a treatment for newly diagnosed glioblastoma multiforme (GBM), the most common form of brain cancer. The conference is being held at the Waldorf Astoria Hotel in New York City and Bradmer's corporate presentation is scheduled on Tuesday, February 12th at 2:45 PM ET in the Bleekman Suite. Dr. Ezrin will also be a panelist at the Neuro-Oncology Workshop, Neuro-oncology: "Breaking Down the Barriers to New Neuro-Oncology Drugs" session on Monday, February 11th from 9:30 to 10:55 AM ET in the East Foyer.

For more information on the BIO CEO & Investor Conference, visit the conference website at http://ceo.bio.org.

About Bradmer Pharmaceuticals Inc. (http://www.bradmerpharma.com)

Bradmer Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of new and innovative cancer therapies. Bradmer's lead clinical candidate, Neuradiab, was developed at Duke University Medical Center as a proprietary therapy for a particularly aggressive form of brain cancer, glioblastoma multiforme. To date, over US$60 million in grants and related support has driven research and development of the licensed treatment, which has been delivered to over 200 patients with promising results and has completed Phase II clinical trials at Duke University. Bradmer is currently in the process of organizing a pivotal multi-center clin
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Bradmer announces additions to Scientific Advisory Board
2. Bradmer Medical Isotope Supply For Phase III Trial Secure
3. Bradmer to present at Rodman & Renshaw Healthcare Conference
4. Bradmer provides Phase III Neuradiab trial update and guidance
5. Bradmer announces management changes
6. Mark Wylie and Suzy Preston Hoover Bring The Biggest Loser Million Pound Tour, Presented by MSN, to Dadeland Mall
7. Stereotaxis to Present at the Deutsche Bank Small- and Mid-Cap Growth Conference
8. QueensLander Tours Presents an Adventure Boot Camp Cruise with John Spencer Ellis from Bravos The Real Housewives of Orange County
9. Assurant President and Chief Executive Officer Robert B. Pollock to Present at Merrill Lynch Insurance Investor Conference on February 12
10. CorVel to Present at UBS Global Healthcare Services Conference
11. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...na-Hong Kong experts concluded that there is a gen...d that SARS is transmitted to human beings through...inese Information Times newspaper on Thursday. T... civet cats, by the Center for Disease Control and...
... and adolescents are enjoying the health and socia...t many observers have noted problems related to// ... while sport medicine physicians have seen alarmin...hletes. The November/December issue of the Clinica...
...mp in funds to the tune of SFr25 million ($20 mill...e of Technology in Lausanne to invest in the creat...r of the brain. The joint venture, envisaged for ... power in children. Also research to lessen the im...
...officials have banned the sale of turbot after the...ish //at several of Beijing’s fish markets, report...d by Cao Jilin from Europe in 1992. Due to low re... on medicinal supplements, which sometime leave ha...
Other Medicine News:Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 2Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 3
(Date:10/6/2008)...a Presented at the American College of Gastroenter...g, ORLANDO, Fla., Oct. 6 /- Combined... American College of Gastroenterology Annual,Scien... that TAK-390MR,resulted in higher healing rates t...rades of erosive esophagitis (EE). TAK-390MR combi...
(Date:10/6/2008)...Data Presented at ACG Annual Scientific Conference...d Pharmaceuticals,(formerly Microbia) today announ...l studies delineating the role that cyclic guanosi...tinal pain. These studies,demonstrate that cGMP in...ntestinal hyperalgesia and desensitizes colonic af...
(Date:10/6/2008)...cuss Promising Research at The American College of...ing, WASHINGTON, Oct. 6 /- New resea...seniors was presented at The American College of,N...ctical Applications of,Probiotics in Health and Di...rics, aging, and nutrition discussed the potential...
(Date:10/6/2008)...MEETING, Pa., Oct. 6 /- Gen...ata from its second Phase 1,clinical trial of trod...e,for the treatment of type 2 diabetes and obesity...ted molecular target that controls the function,of... glucose and decrease,appetite. In the study, MSI-...
Breaking Medicine Technology:Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed 2Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed 3Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Elder Caregiving Site ShirleyBOARD com Wins WebAward for Outstanding Online Community 1587 1Elder Caregiving Site ShirleyBOARD com Wins WebAward for Outstanding Online Community 1587 2Fairness Coalition Applauds Senate Passage of Mental Health Parity Bill 1582 1US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness 324 1US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness 324 2US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness 324 3Pregnancy may slow not accelerate progression to AIDS 1581 1Pregnancy may slow not accelerate progression to AIDS 1581 2Pregnancy may slow not accelerate progression to AIDS 1581 3
... WIRE)--Apr 17, 2007 - Adnexus(TM),Therapeutics, I...ct,"CT-322: A specific VEGFR-2-blocking protein th... models comparable to pan-specific,tyrosine kinase...he,American Association for Cancer Research (AACR)...author is Irvith Carvajal, Ph.D., with,Eric Furfin...
...SS WIRE)--Apr 18, 2007 - Idera,Pharmaceuticals, In...f data for two new potential applications in oncol...(TLR9) at the Annual Meeting of,the American Assoc...s Angeles, CA, April 14-18, 2007. The first presen...s lead oncology candidate,IMO-2055, in combinatio...
Other Medicine Technology:Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 2Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 3Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 4Idera Pharmaceuticals Announces Presentations of Preclinical Data,on New Potential Oncology Applications of its TLR9 Agonists at AACR 2Idera Pharmaceuticals Announces Presentations of Preclinical Data,on New Potential Oncology Applications of its TLR9 Agonists at AACR 3Idera Pharmaceuticals Announces Presentations of Preclinical Data,on New Potential Oncology Applications of its TLR9 Agonists at AACR 4
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: